A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization. - Liu, Chang; Li, Lei; Lu, Wu-sheng; Du, Hua; Yan, Lu-nan; Wen, Tian-fu; Wei, Wu-ran; Jiang, Li; Xu, Ming-qing (BMC Cancer, 2018)